Assessment of morbidity from complete axillary dissection.

[1]  R. Mansel,et al.  The axilla: not a no-go zone , 1991, The Lancet.

[2]  S. Borup Christensen,et al.  Sequelae of axillary dissection vs. axillary sampling with or without irradiation for breast cancer. A randomized trial. , 1989, Acta chirurgica Scandinavica.

[3]  C. Vecht,et al.  Post-axillary dissection pain in breast cancer due to a lesion of the intercostobrachial nerve , 1989, Pain.

[4]  R. Aitken,et al.  Arm morbidity within a trial of mastectomy and either nodal sample with selective radiotherapy or axillary clearance , 1989, The British journal of surgery.

[5]  K. Zedeler,et al.  Breast cancer: risk of axillary recurrence in node-negative patients following partial dissection of the axilla. , 1988, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[6]  D. Easton,et al.  Risk of lymphoedema following the treatment of breast cancer , 1986, The British journal of surgery.

[7]  J. Yarnold.  Selective avoidance of lymphatic irradiation in the conservative management of breast cancer. , 1984, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[8]  B. Brismar,et al.  Postoperative lymphoedema after treatment of breast cancer. , 1983, Acta chirurgica Scandinavica.

[9]  A. B. Price,et al.  THE INADEQUACY OF AXILLARY SAMPLING IN BREAST CANCER , 1982, The Lancet.

[10]  B. Fisher,et al.  Number of lymph nodes examined and the prognosis of breast carcinoma. , 1970, Surgery, gynecology & obstetrics.